Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
83.85
-2.83 (-3.26%)
At close: Apr 28, 2026, 4:00 PM EDT
83.85
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $6.85 billion as of April 28, 2026. Its market cap has increased by 370.58% in one year.
Market Cap
6.85B
Enterprise Value
5.39B
1-Year Change
370.58%
Ranking
Category
Stock Price
$83.85
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $6.85B, an increase of 720.36%. That is a compound annual growth rate of 44.80%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Krystal Biotech | 8.02B |
| Halozyme Therapeutics | 7.74B |
| ImmunityBio | 7.68B |
| Arcellx | 6.75B |
| Erasca | 6.68B |
| Protagonist Therapeutics | 6.38B |
| Belite Bio | 6.34B |
| Apogee Therapeutics | 6.32B |